NM> Vol.3 No.1, March 2012

Common Movement Disorders in Children: Diagnosis, Pathogenesis and Management

DownloadDownload as PDF (Size:231KB) Full-Text HTML PP. 90-100   DOI: 10.4236/nm.2012.31014

ABSTRACT

Movement disorders in childhood are a heterogeneous group of diseases with presentations that vary according to etiopathogenesis and age of onset. While sharing certain characteristics with the conditions that affect adults, they also have unique features that are determined by the metabolic, physiological and environmental distinctiveness of the developing brain. This context makes the nervous system of children vulnerable to various insults such as birth trauma, infections and toxicity. Some inborn errors of metabolism and genetic conditions selectively affect the young brain and psychological adaptation may also contribute to the occurrence and severity of certain conditions at this age group. The present review outlines the pathophysiology, clinical presentation and course, diagnosis and therapy of movement disorders in children. We also emphasize, when available, preventive and prophylactic measures and conclude by suggesting several avenues for future research in aspects that are currently not well understood.

KEYWORDS


Cite this paper

I. Korn-Lubetzki and I. Steiner, "Common Movement Disorders in Children: Diagnosis, Pathogenesis and Management," Neuroscience & Medicine, Vol. 3 No. 1, 2012, pp. 90-100. doi: 10.4236/nm.2012.31014.

References

[1] J. W. Mink, “The Basal Ganglia: Focused Selection and Inhibi-tion of Competing Motor Programs,” Progress in Neurobiology, Vol. 50, No. 4, 1996, pp. 381-425. doi:10.1016/S0301-0082(96)00042-1
[2] J. P. Bolam, J. J. Hanley, P. A. Booth and M. D. Bevan, “Synaptic Organisation of the Basal Ganglia,” Journal of Anatomy, Vol. 196, No. 4, 000, pp. 527-542. doi:10.1046/j.1469-7580.2000.19640527.x
[3] J. W. Mink, “The Basal Ganglia and Involuntary movements: Impaired Inhibition of Competing Motor Patterns,” Archives of Neurology, Vol. 60, No. 10, 2003, pp. 1365-1368. doi:10.1001/archneur.60.10.1365
[4] C. D. Marsden, J. A. Obeso, J. J. Zarranz and A. E. Lang “The Anatomical Basis of Symptomatic Hemidystonia.” Brain; Vol. 108, No. Pt. 2, 1985, pp. 463-483. doi:10.1093/brain/108.2.463
[5] K. P. Bhatia and C. D. Marsden, “The Behavioural and Motor Consequences of Focal Lesions of the Basal Ganglia in Man,” Brain, Vol. 117, No. 4, 1994, pp. 859-876. doi:10.1093/brain/117.4.859
[6] M. Hallett, “Overview of Human Tremor Physiology,” Movement Disorders, Vol. 13, Suppl. 3, 1998, pp. 43-48. doi:10.1002/mds.870131308
[7] J. Jankovic and K. M. Shannon, “Movement Disorders,” In: W. G. Bradley, R. B. Daroff, G. M. Fenichel and J. Jankovic, Ed., Neurology in Clinical Practice, 5th Edition, Butterworth Heinemann Elsevier, Philadelphia, 2008, p. 2081.
[8] B. L. Schlaggar and J. W. Mink, “Movement Disorders in Children,” Pediatric Review, Vol. 24, No. 2, 2003, pp. 39-51. doi:10.1542/pir.24-2-39
[9] R. P. Simon, D. A. Greenberg and M. J. Aminoff, “Movement Disorders,” In: R. P. Simon, D. A. Greenberg and M. J. Aminoff, Ed., Clinical Neurology, 7 Edition, McGraw Hill, New York, 2009.
[10] J. F. Leckman, “Phenomenology of Tics and Natural History of Tic Disorders,” Brain Development, Vol. 25, Suppl. 1, 2003, pp. S24-28. doi:10.1016/S0387-7604(03)90004-0
[11] D. Shprecher and R. Kurlan, “The Management of Tics,” Movement Disorders, Vol. 24, No. 1, 2009, pp. 15-24. doi:10.1002/mds.22378
[12] J. M. Dooley, “Tic Disorders in Childhood,” Seminars in Pediatric Neurology, Vol. 13, No. 4, 2006, pp. 231-242. doi:10.1016/j.spen.2006.09.004
[13] D. S. Wolf and H. S. Singer, “Pediatric Movement Disorders: An Update,” Current Opinion in Neurology, Vol. 21, No. 4, 2008, pp. 491-496. doi:10.1097/WCO.0b013e328307bf1c
[14] M. R. Delgado and A. L. Albright, “Movement Disorders in Children: Definitions, Classifications, and Grading Systems,” Journal of Child Neu-rology, Vol. 18, Suppl. 1, 2003, pp. S1-8.
[15] T. M. O’Shea, “Diagnosis, Treatment, and Prevention of Cerebral Palsy,” Clinical Obstetrics and Gynecology, Vol. 51, No. 4, 2008, pp. 816-828. doi:10.1097/GRF.0b013e3181870ba7
[16] G. Zorzi, F. Zibordi, B. Garavaglia and N. Nardocci, “Early Onset Primary Dystonia,” European Journal of Paediatric Neurology, Vol. 13, No. 6, 2009, pp. 488-492. doi:10.1016/j.ejpn.2008.12.001
[17] F. Cardoso, K. Seppi, K. J. Mair, G. K. Wenning and W. Poewe, “Seminar on Choreas,” Lancet Neurology, Vol. 5, No. 7, 2006, pp. 589-602. doi:10.1016/S1474-4422(06)70494-X
[18] I. Korn-Lubetzki and A. Brand, “Sydenham’s Chorea in Jerusalem: Still Present,” Israel Medical Association Journal, Vol. 6, No. 8, 2004, pp. 460-452.
[19] I. Korn-Lubetzki, A. Brand and I. Steiner, “Recurrence of Sydenham’s Chorea: Implications for Pathogenesis,” Archives of Neurology, Vol. 61, No. 8, 2004, pp. 1261-1264. doi:10.1001/archneur.61.8.1261
[20] Centers for Disease Control and Prevention (CDC), “Prevalence of diagnosed Tourette Syndrome in Persons Aged 6-17 Years United States, 2007,” Morbidity and Mortality Wkeekly Report, Vol. 58, No. 21, 2008, pp. 581-585.
[21] J. F. Leckman, M. H. Bloch, L. Scahill and R. A. King, “Tourette Syndrome: The Self Under Siege,” Journal of Child Neurology, Vol. 21, No. 8, 2006, pp. 642-649. doi:10.1177/08830738060210081001
[22] R. Jin, R. Y. Zheng, W. W. Huang, H. Q. Xu, B. Shao, H. Chen and L. Feng, “Epidemiological Survey of Tourette Syndrome in Children and Adolescents in Wenzhou of P. R. China,” European Journal of Epidemiology, Vol. 20, No. 11, 2005, pp. 925-627. doi:10.1007/s10654-005-2953-z
[23] E. K. Tan, S. Y. Lum and K. M. Prakash, “Clinical Features of Childhood Onset Essential Tremor,” European Journal of Neurology, Vol. 13, No. 12, 2006, pp. 1302-1305. doi:10.1111/j.1468-1331.2006.01471.x
[24] S. K. Das, T. K. Banerjee, T. Roy, D. K. Raut, A. Chau- dhuri and A. Hazra, “Prevalence of Essential Tremor in the City of Kolkata, India: A House-to-House Survey,” European Journal of Neurology, Vol. 16, No. 7, 2009, pp. 801-807. doi:10.1111/j.1468-1331.2009.02589.x
[25] J. Jankovic, J. Madisetty and K. D. Vuong, “Essential Tremor among Child-ren,” Pediatrics, Vol. 114, No. 5, 2004, pp. 1203-1205. doi:10.1542/peds.2004-0031
[26] S. Keller and L. S. Dure “Tremor in Childhood,” Seminar in Pediatric Neurology, Vol. 16, No. 2, 2009, pp. 60-70. doi:10.1016/j.spen.2009.03.007
[27] A. M. Hibbs and S. A. Lorch, “Metoclopramide for the Treatment of Gastroesophageal Reflux Disease in Infants: A Systematic Review,” Pediatrics, Vol. 118, No. 2, 2006, pp. 746-752. doi:10.1542/peds.2005-2664
[28] A. Alvarez-Díaz, E. Hilario, F. G. de Cerio, A. Valls-i-Soler and F. J. Alvarez-Díaz, “ Hypoxic-Ischemic Injury in the Immature Brain: Key Vascular and Cellular Players,” Neonatology, Vol. 92, No. 4, 2007, pp. 227-235. doi:10.1159/000103741
[29] C. McLean and D. Ferriero, “Mechanisms of Hypoxic- Ischemic Injury in the Term Infant,” Seminar in Perinatology, Vol. 28, No. 6, 2004, pp. 425-432. doi:10.1053/j.semperi.2004.10.005
[30] S. Khot and D. L. Tirschwell, “Long-Term Neurological Complications after Hypoxic-Ischemic Encephalopathy,” Seminar in Neurology, Vol. 26, No. 4, 2006, pp. 422-431. doi:10.1055/s-2006-948323
[31] J. Menkes, “Heredodegenerative Diseases,” In: J. H. Menkes, H. B. Sarnat and B. L. Maria, Eds., Child Neurolog, 7th Edition, Lippincott Williams & Wil-kins, Philadelphia, 2005, p. 163.
[32] J. H. Menkes, W. R. Wilcox, “Inherited Metabolic Diseases of the Nervous System,” In: J. H. Menkes, H. B. Sarnat and B. L. Maria, Eds., Child Neurology, 7th Edition, Lippincott Williams & Wilkins, Phila-delphia, 2005, p. 29.
[33] E. Fernandez-Alvarez and J. Aicardi, (Eds.), “Movement Disorders in Children,” MacKeith Press, London, 2001, p. 19.
[34] J. H. Menkes and H. B. Sarnat, “Perinatal Asphyxia and Trauma,” J. H. Menkes, H. B. Sarnat and B. L. Maria, Eds., Child Neurology, 7th Edition, Lippincott Williams & Wilkins, Philadelphia, 2005, p. 367.
[35] R. D. Folkerth, “Neuropathologic Substrate of Cerebral palsy,” Jour-nal of Child Neurology, Vol. 20, No. 12, 2005, pp. 940-949. doi:10.1177/08830738050200120301
[36] M. V. Johnston and A. H. Hoon Jr., “ Possible Mechanisms in Infants for Selective Basal Ganglia Damage from Asphyxia, Kernicterus, or Mitochondrial Encephalopathies,” Journal of Child Neurology, Vol. 15, No. 9, 2000, pp. 588-591. doi:10.1177/088307380001500904
[37] C. Boichot, P. M. Walker, C. Durand, M. Grimaldi, S. Chapuis, J. B. Gouyon and F. Brunotte, “Term Neonate Prognoses after Perinatal Asphyxia: Contributions of MR Imaging, MR Spectroscopy, Relaxation Times, and Apparent Diffusion Coefficients,” Radiology, Vol. 239, No. 3, 2006, pp. 839-848. doi:10.1148/radiol.2393050027
[38] S. M. Shapiro, “Bilirubin Toxicity in the Developing Ner- vous System,” Pediatric Neurology, Vol. 29, No. 5, 2003, pp. 410-421. doi:10.1016/j.pediatrneurol.2003.09.011
[39] J. F. Watchko, “Kernicterus and the Molecular Mechanisms of Bilirubin-Induced CNS Injury in Newborns,” Neuromolecular Medecine, Vol. 8, No. 4, 2006, pp. 513- 529. doi:10.1385/NMM:8:4:513
[40] D. Martino and G. Giovannoni, “Antibasal Ganglia Antibodies and Their Relevance to Movement Disorders”. Current Opinion in Neurology, Vol. 17, No. 4, 2004, pp. 425-432. doi:10.1097/01.wco.0000137532.76491.19
[41] S. T. Shulman, “Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococci (PANDAS): Update,” Current Opinion in Pediatrics, Vol. 21, No. 1, 2009, pp. 127-130. doi:10.1097/MOP.0b013e32831db2c4
[42] R. C. Dale, A. J. Church, R. A. Surtees, A. J. Lees, J. E. Adcock, B. Harding, B. G. Neville, G. Giovannoni, “Encephalitis Lethargica Syndrome: 20 New Cases and Evidence of Basal Ganglia Autoimmunity,” Brain, Vol. 127, No. Pt1, 2004, pp. 21-33. doi:10.1093/brain/awh008
[43] M. W. Kullnat and R. P. Morse, “Choreoathetosis after Herpes Simplex Encephalitis with Basal Ganglia Invol- vement on MRI,” Pediatrics, Vol. 121, No. 4, 2008, pp. e1003-1007. doi:10.1542/peds.2007-0813
[44] S. Ashwal, B. S. Russman, P. A Blasco, G. Miller, A. Sandler, M. Shevell and R. Stevenson, Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society, “Practice Parameter: Diagnostic Assessment of the child with cerebral Palsy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society,” Neurology, Vol. 62, No. 6, 2004, pp. 851-863.
[45] A. H. Hoon Jr., E. M. Reinhardt, R. I. Kelley, S. N. Breiter, D. H. Morton, S. B. Naidu, M. V. Johnston, “Brain Magnetic Resonance Imaging in Suspected Extrapyramidal Cerebral Palsy: Observations in Distinguishing Genetic-Metabolic from Acquired Cause,” Journal of Pediatrics, Vol. 131, No. 2, 1997, pp. 240-245. doi:10.1016/S0022-3476(97)70160-4
[46] M. V. Johnston and A. H. Hoon Jr., “Cerebral Palsy,” Neuromolecular Medecine, Vol. 8, No. 4, 2006, pp. 435- 450. doi:10.1385/NMM:8:4:435
[47] B. S. Russman and S. Ashwal, “Evaluation of the Child with Cerebral Palsy,” Seminar in Pediatric Neurology, Vol. 11, No. 1, 2004, pp. 47-57. doi:10.1016/j.spen.2004.01.007
[48] K. Gkoltsiou, M. Tzoufi, S. Counsell, M. Rutherford and F. Cowan, “ Serial Brain MRI and Ultrasound Findings: Relation to Gestational Age, Bilirubin Level, Neonatal Neurologic Status and Neurodevelopmental Outcome in Infants at Risk of kernicterUs,” Early Human Development, Vol. 84, No. 12, 2008, pp. 829-838. doi:10.1016/j.earlhumdev.2008.09.008
[49] D. L. Gilbert, “Drug-Induced Movement Disorders in Children,” Annals of the New York Academy of Sciences, Vol. 1142, 2008, pp. 72-84. doi:10.1196/annals.1444.005
[50] E. Y. Uc and R. L. Rod-nitzky, “Childhood Dystonia,” Seminar in Pediatric Neurology, Vol. 10, No. 1, 2003, pp. 52-61. doi:10.1016/S1071-9091(02)00010-4
[51] C. U. Correll and E. M. Schenk, “Tardive dyskinesia and new antipsychotics,” Cur-rent Opinion in Psychiatry, Vol. 21, No. 2, 2008, pp. 151-156. doi:10.1097/YCO.0b013e3282f53132
[52] C. U. Correll and J. M. Kane, “One-Year Incidence Rates of Tardive Dyskinesia in Children and Adolescents Treated with Second-Generation Antipsychotics: A Systematic Review,” Journal of Child and Adolescent Psychopharmacology, Vol. 17, No. 5, 2007, pp. 647-656. doi:10.1089/cap.2006.0117
[53] N. Gordon, “Sydenham’s Chorea and Its Complications Affecting the Nervous System,” Brain and Development, Vol. 31, No. 1, 2009, pp. 11-14. doi:10.1016/j.braindev.2008.05.001
[54] R. Kurlan, D. Johnson, E. L. Kaplan and the Tourette Syndrome Study Group, “Streptococcal Infection and Exacerbations of Childhood Tics and Obsessive-Compulsive Symptoms: A Prospective Blinded Cohort Study,” Pediatrics, Vol. 121, No. 6, 2008, pp. 1188-1197. doi:10.1542/peds.2007-2657
[55] S. E. Swedo, H. L. Leonard, M. Garvey, B. Mittleman, A. J. Allen, S. Perlmutter, L. Lougee, S. Dow, J. Zamkoff, and B. K. Dubbert, “Pediatric Autoimmune Neuropsychi- atric Disorders Associated with Streptococcal Infections: Clinical Description of the First 50 Cases,” American Journal of Psychiatry, Vol. 155, No. 2, 1998, pp. 2264- 2371.
[56] V. Gabbay, B. J. Coffey, J. S. Babb, L. Meyer, C. Wach- tel, S. Anam and B. Rabinovitz, “Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcus: Comparison of Diagnosis and Treatment in the Community and at a Specialty Clinic,” Pediatrics, Vol. 122, No. 3, 2008, pp. 273-278. doi:10.1542/peds.2007-1307
[57] S. J. Hayflick, S. K. Westa-way, B. Levinson, B. Zhou, M. A. Johnson, K. H. Ching and J. Gitschier, “Genetic, Clinical, and Radiographic Delineation of Hallervorden-Spatz Syndrome,” New England Journal of Med-icine, Vol. 348, No. 1, 2003, pp. 33-40. doi:10.1056/NEJMoa020817
[58] A. Machado, H. F. Chien, M. M. Deguti, E, Can?ado R. S. Azevedo, M. Scaff and E. R. Barbosa, “Neurological Ma- nifestations in Wilson’s Disease: Report of 119 Cases,” Movement Disorder, Vol. 21, No. 2, 2006, pp. 2192-2196. doi:10.1002/mds.21170
[59] J. Klepper and B. Leiendecker, “GLUT1 Deficiency Syndrome: 2007 Update,” Developmental Medicine and Child Neurology, Vol. 49, No. 9, 2007, pp. 707-716. doi:10.1111/j.1469-8749.2007.00707.x
[60] J. W. Mink and L. S. Dure, “Paroxysmal Movement Disorders in Childhood,” In: B. L. Maria, Ed., Current Management in Child Neurology, 3rd Edition, BC Decker, Hamilton (Canada), 2005, p. 427.
[61] N. Kabaku? and A. Kurt, “Sandifer Syndrome: a continuing Problem of Misdiagnosis,” Pediatric International, Vol. 48, No. 6, 2006, pp. 622-625. doi:10.1111/j.1442-200X.2006.02280.x
[62] A. S. Golden, S. R. Haut and S. L. Moshé, “Nonepileptic uses of Antiepileptic Drugs in Children and Adolescents,” Pediatric Neurology, Vol. 34, No. 6, 2006, pp. 421-432. doi:10.1016/j.pediatrneurol.2005.08.017
[63] F. J. Jiménez-Jiménez and P. J. García-Ruiz, “Pharmacological Options for the Treatment of Tourette’s Disorder,” Drugs, Vol. 61, No. 15, 2001, pp. 2207-2220.
[64] M. A. Gerber, R. S. Baltimore, C. B. Eaton, M. Gewitz, A. H. Rowley, S. T. Shulman and K. A. Taubert, “Prevention of Rheumatic Fever and Diag-nosis and Treatment of Acute Streptococcal Pharyngitis: A Scientific Statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Com-mittee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Trans- lational Biology, and the Interdisciplinary Council on Quality of Care an
[65] J. Rice and M. C. Waugh, “Pilot Study on Trihexyphenidyl in the Treatment of Dystonia in Children with Cerebral Palsy,” Journal of Child Neurology, Vol. 24, No. 2, 2009, pp. 176-182. doi:10.1177/0883073808322668
[66] M. M. Qasaymeh and J. W. Mink, “New Treatments for Tic Disorders,” Current Treatment Options in Neurology, Vol. 8, No. 6, 2006, pp. 465-473. doi:10.1007/s11940-006-0036-4
[67] R. Nicolson, B. Craven-Thuss, J. Smith, B. D. McKinlay and F. X. Castellanos, “A Randomized, Double-Blind, Placebo-Controlled Trial of Metoclopramide for the Treatment of Tourette’s Disorder,” Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 44, No. 7, 2005, pp. 640-646. doi:10.1097/01.chi.0000163279.39598.44
[68] R. J. Stephens, C. Bassel and P. Sandor, “Olanzapine in the Treatment of Aggression and Tics in Children with Tourette’s Syndrome: A Pilot Study,” Journal of Child and Adolescent Psychopharmacology, Vol. 14, No. 2, 2004, pp. 255-266. doi:10.1089/1044546041648959
[69] G. R. Gaffney, P. J. Perry, B. C. Lund, K. A. Bever-Stille, S. Arndt and S. Kuper-man, “Risperidone versus Clonidine in the Treatment of Children and Adolescents with Tourette’s Syndrome,” Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 41, No. 3, 2002, pp. 330- 336. doi:10.1097/00004583-200203000-00013
[70] Tourette’s Syndrome Study Group, “Treatment of ADHD in Children with Tics: A Randomized Controlled Trial,” Neurology, Vol. 58, No. 4, 2002, pp. 527-536.
[71] M. Vidailhet, L. Vercueil, J. L. Houeto, P. Krystkowiak, C. Lagrange, J. Yelnik, E. Bardinet, A. L. Benabid, S. Navarro, D. Dormont, S. Grand, S. Blond, C. Ardouin, B. Pillon, K. Dujardin, V. Hahn-Barma, Y. Agid, A. Destée, P. Pollak and French SPIDY Study Group, “Bilateral, Pallidal Deep Brainstimulation in Primary Generalized Dystonia: A Prospective 3 Year Follow-Up Study,” Lancet Neurology, Vol. 6, No. 3, 2007, pp. :223-229.
[72] W. A. Marks, J. Honeycutt, F. Acosta and M. Reed, “Deep Brain Stimulation for Childhood onset Dystonias at Cook Children’s Medical Center, a Community Based Pediatric Hospital,” Semiar in Pediatric Neurology, Vol. 16, No. 2, 2009, pp. 90-98. doi:10.1016/j.spen.2009.04.001
[73] D. Servello, M. Porta, M. Sassi, A. Brambilla and M. M. Robertson, “Deep Brain Stimu-lation in 18 Patients with Severe Gilles de la Tourette Syndrome Refractory to Treatment: The Surgery and Stimulation,” Journal of Neurology Neurosurgery and Psychiatry, Vol. 79, No. 2, 2008, pp. 136-142. doi:10.1136/jnnp.2006.104067
[74] R. J. Maciunas, B. N. Maddux, D. E. Riley, C. M. Whitney, M. R. Schoenberg, P. J. Ogrocki, J. M. Albert and D. J. Gould, “Prospective Randomized Double-Blind Trial of Bilateral Thalamic Deep Brain Stimulation in Adults with Tourette Syndrome,” Journal of Neurosurgery, Vol.107, No. 5, 2007 pp. 1004-1014. doi:10.3171/JNS-07/11/1004
[75] J. Shahed, J. Poysky, C. Kenney, R. Simpson and J. Jankovic, “GPi Deep Brain Stimu-lation for Tourette Syndrome Improves Tics and Psychiatric Comorbidities,” Neurology, Vol. 68, No. 2, 2007, pp 159-160. doi:10.1212/01.wnl.0000250354.81556.90

comments powered by Disqus

Copyright © 2014 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.